In Tokyo for ‘Antibody Engineering & Therapeutics, Asia’
This week’s Antibody Engineering & Therapeutics conference aims to bring together world-renowned scientists sharing the latest technologies, R&D and clinical data to fast-track next-generation therapeutics towards commercial success. The event is being held in Tokyo, Japan.
Mark Aspinall-O’Dea will be presenting strategies for uncovering critical receptor targets and assessing the specificity of biotherapeutics, using case studies from industry partners and academic collaborators. We will also be exhibiting at the meeting.
For further details, please see the conference website. To arrange a presentation on our technology, or to discuss a project please get in touch.